Contact
Please use this form to send email to PR contact of this press release:
ROSEN, A LEADING AND LONGSTANDING FIRM, Encourages Eiger BioPharmaceuticals, Inc. Investors to Secure Counsel Before Important January 9 Deadline in Securities Class Action – EIGR
TO: